Description
KLOW is an advanced quad-peptide research blend combining four synergistic compounds for comprehensive multi-pathway tissue support and immune modulation research.
Research Profile
This flagship formulation unites KPV’s NF-κB-mediated anti-inflammatory signaling, BPC-157’s cytoprotective and angiogenic properties, TB-500’s actin dynamics and cell migration promotion, and GHK-Cu’s broad gene-modulatory and ECM-remodeling effects. The high-concentration GHK-Cu component (50 mg) ensures robust metalloproteinase and growth factor signaling throughout extended research timelines. This is our most comprehensive tissue-support research blend.
Quad-Peptide BlendMulti-Pathway4-Component Formula≥98% Purity
This product is not a drug, dietary supplement, or food. It is not intended to diagnose, treat, cure, or prevent any disease. No claims are made regarding biological activity, outcomes, or effects. By purchasing this product, the buyer acknowledges that it is for research use only and agrees to handle, store, and dispose of it in accordance with all applicable laws and regulations.





Reviews
There are no reviews yet.